-
effectivehealthcare.ahrq.gov/sites/default/files/s9.pdf
October 01, 2007 - ORIGINAL ARTICLE
Medicare Part D Data
Major Changes on the Horizon
Leslie M. Greenwald, PhD
Background: The 3 primary administrative data sets developed by
the Centers for Medicare and Medicaid services (CMS) to support
the Medicare Part D program implementation represent a valuable
source of data for health service…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - Failure to stratify or
disaggregate outcome data according to the treatment
Table A. … This trial was considered to have a high
risk of bias, primarily due to failure to provide details … Upon
local failure, patients enter into a new category centered on systemic chemotherapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
April 01, 2014 - enema alone or no
preparation, only two provided information on harms
(1 for nausea and 1 for renal failure … patients receiving OMBP versus
1 of 89 patients receiving no preparation experienced
acute renal failure … Renal
failure, an outcome considered important given that many
OMBP strategies involve ingestion of
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
February 24, 2016 - issue with the statement “The higher
local recurrence rate does not necessarily indicate a biological failure … By definition of more than one treatment is required, IT DOES
INDICATE BIOLOGICAL FAILURE of the treatment … Furthermore, this
contradicts the prior endorsement of the Definition of primary treatment
failure
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
June 01, 2014 - However, in May 2014, Corcept halted development of mifepristone for this indication,
citing a failure … potential at this time, citing three reasons: limited efficacy data for treating binge-eating
disorder, failure … negative associations, resulting in limited patient engagement, reduced
adherence to treatment, and failure
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-tools_research-protocol.pdf
April 14, 2016 - in relevant populations and settings including the intensive care unit, oncology,
pediatrics, heart failure
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - include
but are not limited to nausea, diarrhea, headache, tremor, daytime sedation,
decreased libido, failure
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
March 01, 2018 - Allergen specific
immunotherapy induced multi-organ failure.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - baseline
disease severity, affected BSA, disease location, number
and type of previous treatments, failure
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pain-chronic_disposition-comments.pdf
September 01, 2011 - I believe that they attribute
insurance tactics to their failure too frequently.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
May 01, 2012 - of a
psychosocial
and/or
pharmacological
treatment to an
existing treatment
after treatment
failure … and
psychosocial interventions, as either the initial line of treatment or as the option following failure … Addition of a
psychosocial and/or
pharmacological
treatment to an
existing treatment
after treatment
failure … The natural history of congestive heart
failure: the Framingham study.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
January 01, 2013 - Background
Iron overload increases the risk for liver disease (cirrhosis, cancer), heart attack or heart
failure … Contribution of iron deficiency to anemia in
chronic renal failure. … ferritin
(ZPP/logSF index) in the detection of iron
deficiency in patients with end-stage renal
failure … Markers of masked iron deficiency and
effectiveness of EPO therapy in chronic
renal failure.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
May 04, 2013 - tubes used
_ Average duration of TT insertion
_ Type of follow-up
_ Potential causation of tube failure … "Few studies provided a power analysis so making it difficult to interpret
failure to find differences … Without such information, we
could not determine with confidence whether a
failure to find differences … The failure to recognize that there were no
comparisons between adenoidectomy and no intervention means
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
January 01, 2019 - 1 vs. 7
Reoperation type
Decompression: 4 vs. 18
Fusion: 12 vs. 45 NR Cardiac event: 3 vs. 0
Kidney failure … but sham tip received no current and remained at body temp NR Allowed after 3 months for treatment failure … reduction following the index treatment, for FJI and C-LRFA, respectively), and not counted as a treatment failure … Crossover before 12 months considered treatment failure
A vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
March 01, 2013 - treatment-related adverse events (e.g., drug side effects); does not include consequences related to the failure … include lactic acidosis,
serious hypoglycemia (most often in combination with
other agents) and liver failure
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
December 01, 2015 - those requiring ongoing daily
medication use for conditions such as tuberculosis, diabetes, heart failure … Failure to determine these thresholds during Phase 2
is believed to be one of the main reasons for
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
June 01, 2015 - those requiring ongoing daily medication use for conditions such as tuberculosis, diabetes,
heart failure … Failure to determine these thresholds during Phase 2 is
believed to be one of the main reasons for
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - track medication adherence in patients with chronic conditions such as
tuberculosis, diabetes, heart failure … Failure to determine these thresholds
during Phase 2 is believed to be one of the main reasons for
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_disposition-comments.pdf
June 12, 2013 - We believe this failure has prevented us from
contributing meaningfully to the benefit of patients and … apparent adjustment was made to the data to
account for those who received systemic therapies
after failure
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - had been approved
in Europe for the treatment of symptomatic anemia associated with chronic renal failure … clinical
trials.34-36 Erythropoietin was first approved for the treatment of anemia in chronic
kidney failure